Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Karen Huaman Sanchez; Fabiola Huaroto; Catherine Bonilla; Adolfo Aramburú; Javier Morales Barrenechea; Ericson L. Gutiérrez; Maricela Curisinche; Daniel Rojas Bolivar; Diana Maria Gonzales Zurita; Jose Carlos Sánchez-Ramírez; Nora Reyes Puma

doi:10.35434/rcmhnaaa.2022.15Supl.1.1542

Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Karen Huaman Sanchez, Fabiola Huaroto, Catherine Bonilla, Adolfo Aramburú, Javier Morales Barrenechea, Ericson L. Gutiérrez, Maricela Curisinche, Daniel Rojas Bolivar, Diana Maria Gonzales Zurita, Jose Carlos Sánchez-Ramírez, Nora Reyes Puma

Facultad de ciencias de la salud

Producción científica: Artículo Científico › Artículo original › revisión exhaustiva

Resumen

The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

Título traducido de la contribución	Use of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health
Idioma original	Español
Publicación	Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
Volumen	15
DOI	https://doi.org/10.35434/rcmhnaaa.2022.15Supl.1.1542
Estado	Indizado - set. 2022

Nota bibliográfica

Publisher Copyright:
© 2022 Publicado por Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.

Palabras clave

COVID-19
GRADE approach
Perú
Policy Making
evidence-informed policy-making

Acceder al documento

10.35434/rcmhnaaa.2022.15Supl.1.1542

Citar esto

Sanchez, K. H., Huaroto, F., Bonilla, C., Aramburú, A., Barrenechea, J. M., Gutiérrez, E. L., Curisinche, M., Bolivar, D. R., Zurita, D. M. G., Sánchez-Ramírez, J. C., & Puma, N. R. (2022). Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud. Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, 15. https://doi.org/10.35434/rcmhnaaa.2022.15Supl.1.1542

@article{83dc207356544ed68a309581c5f7f93c,

title = "Uso de la evidencia durante la pandemia de COVID-19 en el Per{\'u}, aportes del Instituto Nacional de Salud",

abstract = "The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health{\textquoteright}s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19{\textquoteright}s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.",

keywords = "COVID-19, GRADE approach, Per{\'u}, Policy Making, evidence-informed policy-making",

author = "Sanchez, {Karen Huaman} and Fabiola Huaroto and Catherine Bonilla and Adolfo Arambur{\'u} and Barrenechea, {Javier Morales} and Guti{\'e}rrez, {Ericson L.} and Maricela Curisinche and Bolivar, {Daniel Rojas} and Zurita, {Diana Maria Gonzales} and S{\'a}nchez-Ram{\'i}rez, {Jose Carlos} and Puma, {Nora Reyes}",

note = "Publisher Copyright: {\textcopyright} 2022 Publicado por Cuerpo M{\'e}dico Hospital Nacional Almanzor Aguinaga Asenjo.",

year = "2022",

month = sep,

doi = "10.35434/rcmhnaaa.2022.15Supl.1.1542",

language = "Espa{\~n}ol",

volume = "15",

journal = "Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo",

issn = "2225-5109",

publisher = "Cuerpi Medico del Hospital Nacional Almanzor Aguinaga Asenjo (HNAAA)",

}

Sanchez, KH, Huaroto, F, Bonilla, C, Aramburú, A, Barrenechea, JM, Gutiérrez, EL, Curisinche, M, Bolivar, DR, Zurita, DMG, Sánchez-Ramírez, JC & Puma, NR 2022, 'Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud', Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, vol. 15. https://doi.org/10.35434/rcmhnaaa.2022.15Supl.1.1542

TY - JOUR

T1 - Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

AU - Sanchez, Karen Huaman

AU - Huaroto, Fabiola

AU - Bonilla, Catherine

AU - Aramburú, Adolfo

AU - Barrenechea, Javier Morales

AU - Gutiérrez, Ericson L.

AU - Curisinche, Maricela

AU - Bolivar, Daniel Rojas

AU - Zurita, Diana Maria Gonzales

AU - Sánchez-Ramírez, Jose Carlos

AU - Puma, Nora Reyes

PY - 2022/9

Y1 - 2022/9

N2 - The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

AB - The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

KW - COVID-19

KW - GRADE approach

KW - Perú

KW - Policy Making

KW - evidence-informed policy-making

UR - http://www.scopus.com/inward/record.url?scp=85152923232&partnerID=8YFLogxK

U2 - 10.35434/rcmhnaaa.2022.15Supl.1.1542

DO - 10.35434/rcmhnaaa.2022.15Supl.1.1542

M3 - Artículo original

AN - SCOPUS:85152923232

SN - 2225-5109

VL - 15

JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo

JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo

ER -

Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Resumen

Nota bibliográfica

Palabras clave

Acceder al documento

Huella

Citar esto